Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06591286
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-07
Brief Title:
Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose Control
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose Control and Self-efficacy Among Patients with Type 2 Diabetes Treated with Insulin
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Glucose monitoring is an important part of self-management for patients with diabetes The results of glucose monitoring not only help to assess the degree of glucose metabolism disorders in patients but also help physicians to make clinical decisions and guide patients in self-management Despite extensive efforts and advances in diabetes management during hospitalization glucose control after patients is discharged home remains a challenge This trial aims to explore the effect of real-time continuous glucose monitoring RT-CGM system compared to self-monitoring of blood glucose SMBG group on glucose and self-efficacy of type 2 diabetes patients treated with insulin after discharge from the hospital
Detailed Description:
Glycemic management of patients with diabetes after discharge home is extremely challenging especially for those requiring insulin therapy The use of a real-time continuous glucose monitoring RT-CGM system may improve glycemic control and self-efficacy in patients with type 2 diabetes treated with insulin after discharge from the hospital
One hundred and fifty insulin-treated adults with type 2 diabetes were randomly assigned to receive either RT-CGM or self-monitoring of blood glucose SMBG at hospital discharge for a 12-week monitoring intervention and a 36-week follow-up
One hundred and fifty insulin-treated adults with type 2 diabetes were randomly assigned to receive either RT-CGM or self-monitoring of blood glucose SMBG at hospital discharge for a 12-week monitoring intervention and a 36-week follow-up
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None